Pergolide Mesilate

培高利特甲磺酸酯

Report date: 2022/08/17 14:43:15
NME

Base Information

Drug NamePergolide Mesilate
Drug Alias Name硫丙麦角林Pergolide Mesylatepergolidum培高莱pergolida +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonistsDopamine D2 receptor agonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsCocaine-Related DisordersSubstance-Related DisordersParkinson Disease
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryUnited States
Original Approved Date1988/12/30
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute On Drug AbuseMedical University Of South CarolinaBausch Health Companies Inc +[4] 
Active IndicationsN/A
Inactive IndicationsCocaine-Related DisordersSubstance-Related DisordersParkinson Disease

Other Information

ATC CodeN04BC02
Related LinksWikipediaDrugBankKEGG